 |
Hidde Ploegh, PhD
Our bodies are in a constant state of war with countless
microbes mounting attacks on us. Since 1981, Hidde
Ploegh has been researching the dynamics of this protracted
chess game between our bodies and these outside invaders.
|
Selected Achievements
• Annual Prize, Dutch Society for Biochemistry
(1984)
• Member, European Molecular Biology
Organization (1986)
• Correspondent, Royal Dutch Academy of
Sciences (1997)
• National Institutes of Health Merit Award
(1997)
• Member, American Academy of Arts and Sciences
(2000)
• Avery-Landsteiner Prize (2000)
• Havinga Medal, Leiden University (2004)
• Interbrew-Baillet Latour Health Prize (2006) |
One of the world’s leading researchers in immune
system behavior, Ploegh studies the various tactics
that viruses employ to evade our immune responses,
and the ways in which our immune system distinguishes
friend from foe. He discusses one aspect of his work—research
on flu viruses—in a video (220
kbps or 56
kbps QuickTime).
Among his achievements, in 2002 Ploegh and his laboratory
reported a new mechanism by which dendritic cells sense
the presence of antigens and instruct the immune response.
Using fluorescent imaging, the researchers could watch
the dentritic cell carry out its task in real time.
In addition, Ploegh has helped elucidate how a certain
set of glycoproteins—molecules that help the immune
system recognize invaders—are put together and
are delivered to the right destination to help an immune
response kick in. He and his fellow researchers also
discovered a new mechanism by which viruses evade the
immune system.
Lately, Ploegh and his coworkers have been particularly
interested in generating the chemical tools with which
to probe a particular family of enzymes called proteases
that are a key component of the Ubiquitin-proteasome
system, one of the major mechanisms by which proteins
are degraded in cells.
A contributor to over 300 papers, Ploegh comes to Whitehead
from the Harvard Medical School where, as Professor
of Pathology, he has been heading the school’s
immunology program since 1997. Prior to that, Ploegh
was a Professor of Biology at MIT, working in the Center
for Cancer Research.
Selected Publications
Lilley, B. N., and H. L. Ploegh. 2004. A membrane
protein required for dislocation of misfolded proteins
from the ER. Nature 429:834.
Borodovsky, A., H. Ovaa, N. Kolli, T. Gan-Erdene, K.
D. Wilkinson, H. L. Ploegh, and B. M. Kessler. 2002.
Chemistry-based functional proteomics reveals novel
members of the deubiquitinating enzyme family.
Chem Biol 9:1149.
Boes, M., J. Cerny, R. Massol, M. Op den Brouw, T.
Kirchhausen, J. Chen, and H. L. Ploegh. 2002. T-cell
engagement of dendritic cells rapidly rearranges MHC
class II transport. Nature 418:983.
Wiertz, E. J., D. Tortorella, M. Bogyo, J. Yu, W. Mothes,
T. R. Jones, T. A. Rapoport, and H. L. Ploegh. 1996.
Sec61-mediated transfer of a membrane protein from
the endoplasmic reticulum to the proteasome for destruction.
Nature 384:432.
Wiertz, E. J., T. R. Jones, L. Sun, M. Bogyo, H. J.
Geuze, and H. L. Ploegh. 1996. The human cytomegalovirus
US11 gene product dislocates MHC class I heavy chains
from the endoplasmic reticulum to the cytosol.
Cell 84:769.
[publications
(pubmed database)] |
 |